Avoiding Counterfeit Medication

Many compounding pharmacies have attempted to copy and sell formulations of Transdermal Verapamil 15% Gel, claiming them to be the same as PDLabs' patented and clinically studied formulation. These claims are not true. Transdermal Verapamil 15% Gel for treating fibrotic tissue disorders such as Peyronie's disease, plantar fibromatosis, Dupuytren's contracture and scarring is protected by U.S. Patent numbers 6,031,005 and 6,353,028. PDLabs' technology has not been licensed to any pharmacy.

Counterfeit Medication Can Be Unsafe And Is Not Proven To Work

Transdermal Verapamil 15% Gel compounded by local compounding pharmacies has not undergone any testing for potency, stability, effectiveness, or safety. PDLabs has conducted and continues to conduct ongoing testing and research in each of these areas. Patients who have received counterfeit Transdermal Verapamil 15% Gel have reported:

• Changes in blood pressure
• Severe skin irritation
• Skin burns

Compounding pharmacies do not conduct controlled clinical trials of any kind on their compounded formulations. As a result, you will be receiving medication with no proven success.

Identifying Pharmacies That Make Counterfeit Transdermal Verapamil 15% Gel

Any of the following items can be used to identify pharmacies compounding illegal Transdermal Verapamil 15% Gel:

• They claim that PDLabs has authorized them to make Transdermal Verapamil 15% Gel
• They claim to use earlier issued patents to legally make Transdermal Verapamil 15% Gel
• They claim that their formula is different from PDLabs and that makes it legal for them to make it
• Information and graphics have been cut and pasted from PDLabs website to theirs
• The pharmacist can not answer specific questions about how Transdermal Verapamil 15% Gel treats your condition or why you should avoid certain drugs and supplements

Identifying Counterfeit Transdermal Verapamil 15% Gel

Some counterfeits may be easy to identify and others may look very similar and have similar characteristics to PDLabs' Transdermal Verapamil 15% Gel. The following tips will help you to identify counterfeit medication.

• The medication is not dispensed with the proper application instructions
• The medication is packed into any of the following:
  • Plastic syringes
  • Jars of any kind
  • Metal or plastic tubes
• There should be no crystals, granules, or grit.
• The medication should be amber/yellow in color not white or clear
• The medication should not become runny over time

If you feel you have received counterfeit medication and have any questions please contact PDLabs.

next: Insurance

Copyright © 2007 PDLabs Inc. All rights reserved. Privacy Policy.

The information contained in this website is provided for educational purposes only and is not intended to replace discussions with your healthcare provider. All decisions regarding a patients' treatment must be made with a healthcare provider.

Transdermal Verapamil 15% Gel is available as a compounded medication exclusively from PDLabs. Transdermal Verapamil 15% Gel is not FDA approved. PDLabs is not an "internet pharmacy" and requires that an appropriate doctor-patient-pharmacist relationship be maintained. PDLabs will not fill prescriptions for patients that do not have a valid patient-doctor relationship.

Transdermal Verapamil 15% Gel is not for everyone. Patients with specific heart conditions known as atrioventricular (AV) block or Sino-Atrial (SA) block should not use calcium channel blockers such as verapamil. Patients taking the antiarrhythmic drug Tikosyn® (Dofetilide) should not use Transdermal Verapamil 15% Gel.

Patients taking digoxin or cyclosporine should have their drug levels monitored on a regular basis as verapamil may decrease the metabolism and clearance of these drugs. Patients taking antiarrhythmic drugs should consult with their doctor before taking Transdermal Verapamil 15% Gel to ensure it is safe to use. A PDLabs pharmacist can help with this discussion.

The most common side effect reported with Transdermal Verapamil 15% Gel, affecting 3-5% of Peyronie's disease patients, is varying degrees of skin irritation. Some patients using the medication for the first time may experience mild itching/irritation during the first few days of treatment. This is normal and usually resolves within 3-4 days. Other patients may experience more severe contact dermatitis, including itching, burning, redness, or swelling. More persistent or severe irritation can usually be treated with topical corticosteroids. Based on the individual symptoms, PDLabs will work with the patient and prescribing physician to determine the best course of treatment to resolve irritation.